ARKOROYAL ROYAL FRUITS + VITAMINE B3
Integratore alimentare dichiarato in Francia, notifica n. 2018-10-1169
ARKOROYAL ROYAL FRUITS + VITAMINE B3, dell'azienda LABORATOIRES ARKOPHARMA, è un integratore alimentare dichiarato in Francia. Stato: ritirato dal mercato il 1 ottobre 2021. Ingredienti principali: Lycium barbarum 600 mg al giorno, Punica granatum 200 mg al giorno, Psidium guajava 40,7 mg al giorno, Adansonia digitata 15 mg al giorno, Citrus limon 13,5 mg al giorno. 1 norma d’uso si applica ai suoi ingredienti (limiti e avvertenze).
- Marca
- ARKOROYAL
- Responsabile dell’immissione in commercio
- LABORATOIRES ARKOPHARMA
- Stato
- Ritirato dal mercato il 1 ottobre 2021
- Forma
- Fiala
- Dose giornaliera
- Modalità d’uso
Testo originale in francese.
1 ampoule au petit-déjeuner, de préférence diluée dans un verre d’eau ou de jus de fruits (200 ml)
- Sconsigliato (secondo il fabbricante)
- In trattamento con anticoagulanti
Notifica 159377, procedura Article 16. Compl’Alim, dichiarazioni di integratori alimentari, consultato il 15 novembre 2026.
Composizione dichiarata
Piante
| Pianta | Parte | Preparazione | Al giorno |
|---|---|---|---|
| Lycium barbarum L. | Baie | Extrait fluide aqueux | 600 mg |
| Punica granatum L. | Fruit | Extrait fluide aqueux | 200 mg |
| Psidium guajava L. | Fruit | Extrait sec aqueux | 40,7 mg |
| Adansonia digitata L. | Fruit (pulpe) | Poudre (de plantes séchées ou broyées) | 15 mg |
| Citrus limon (L.) Burm. f. | Péricarpe | Extrait sec aqueux | 13,5 mg |
| Ocimum tenuiflorum L. | Feuille | Extrait sec aqueux | 13,5 mg |
Altri ingredienti attivi
| Nome | Al giorno |
|---|---|
| miel | non dichiarata |
| Gelée royale | non dichiarata |
Additivi
E960, E414
Altri ingredienti
eau, jus d'orange
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Avvertenze dell’etichetta
Testo originale in francese.
Déconseillé aux personnes qui ont des antécédents d’allergies aux produits de la ruche. Le goji peut interagir avec les traitements anticoagulants de la classe des anti-vitamines K. Demandez conseil à votre médecin.Aspetti normativi
- Conditions légales
Psidium guajava L.: Seule l'utilisation des extraits aqueux et alcooliques de titre faible (25% v/v) est autorisée
Fonte: Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, arrêté du 24 juin 2014, annexe I.
- Information
Ritirato dal mercato il 1 ottobre 2021, secondo Compl'Alim.
Fonte: Compl’Alim, dichiarazioni di integratori alimentari.
Queste informazioni riprendono la dichiarazione del fabbricante all’amministrazione (DGAL). Non dicono se il prodotto sia efficace e non sostituiscono il parere di un medico o farmacista, in particolare in gravidanza o durante un trattamento.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Punica granatum L.
Leggere l'avvertenza, quando si applica e gli studi citati
- Ocimum tenuiflorum L.
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
HOLY BASIL - OCIMUM TENUIFLORUM - SEED
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a cardiovascular condition (Rai et al. 1997; Agrawal et al. 1996).
Fonti citate da Health Canada (2)
- Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 1996;34(9):406-409. PubMed Studio randomizzato
- Rai V, Iyer U, Mani UV. Effect of Ocimum sanctum leaf powder on blood lipoproteins, glycated proteins and total amino acids in patients with non-insulin-dependent diabetes mellitus. Journal of Nutritional and Environmental Medicine. 1997;7(2):133-118. PubMed
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any heart or blood pressure medication (Rai et al. 1997; Agrawal et al. 1996).
Fonti citate da Health Canada (2)
- Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 1996;34(9):406-409. PubMed Studio randomizzato
- Rai V, Iyer U, Mani UV. Effect of Ocimum sanctum leaf powder on blood lipoproteins, glycated proteins and total amino acids in patients with non-insulin-dependent diabetes mellitus. Journal of Nutritional and Environmental Medicine. 1997;7(2):133-118. PubMed
Condizione di applicazione: Relief of cough; Digestive aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 27 febbraio 2026
HOLY BASIL - OCIMUM TENUIFLORUM - LEAF
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (WHO 2002).
Fonti citate da Health Canada (2)
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Genève (CH) : Organisation mondiale de la santé; 2002.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a heart condition or diabetes (Rai et al. 1997; Agrawal et al. 1996).
Fonti citate da Health Canada (2)
- Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 1996;34(9):406-409. PubMed Studio randomizzato
- Rai V, Iyer U, Mani UV. Effect of Ocimum sanctum leaf powder on blood lipoproteins, glycated proteins and total amino acids in patients with non-insulin-dependent diabetes mellitus. Journal of Nutritional and Environmental Medicine 1997;7(2):133-118. PubMed
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any heart or blood pressure medication (Rai et al. 1997; Agrawal et al. 1996).
Fonti citate da Health Canada (2)
- Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 1996;34(9):406-409. PubMed Studio randomizzato
- Rai V, Iyer U, Mani UV. Effect of Ocimum sanctum leaf powder on blood lipoproteins, glycated proteins and total amino acids in patients with non-insulin-dependent diabetes mellitus. Journal of Nutritional and Environmental Medicine 1997;7(2):133-118. PubMed
Condizione di applicazione: Relief of cough/cold/respiratory mucus buildup; Digestive aid; Adaptogen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Controindicazioni
Do not use if you are pregnant (Prakash et al. 2005; Ahmed et al. 2002; WHO 2002; Wohlmuth 2002; Kapoor 2001).
Fonti citate da Health Canada (6)
- Ahmed A, Ahamed RN, Aladakatti RH, Ghoseawar MG. Reversible antifertility effect of benzene extract of Ocimum sanctum on sperm parameters and fructose content in rats. Journal of basic and clinical physiology and pharmacology 2002;13:51-59. PubMed
- Kapoor LD. Handbook of Ayurvedic Medicinal Plants. Baton Roca (FL): CRC Press LLC; 2001.
- Prakash P, Gupta N. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian Journal of Physiology and Pharmacology 2005;49(2):125-131. PubMed Articolo di revisione
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CH): World Health Organization; 2002.
- Wohlmuth H. Sacred basil - an Ayurvedic adaptogen. Botanical Pathways, 2002; Issue 11.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Genève (CH) : Organisation mondiale de la santé; 2002.
- Gelée royale
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ROYAL JELLY
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Controindicazioni
Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).
Fonti citate da Health Canada (8)
- Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Caso clinico
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Caso clinico
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Caso clinico
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Caso clinico
- TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
Reazioni avverse note
Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).
Fonti citate da Health Canada (6)
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Caso clinico
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Caso clinico
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Caso clinico
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
Marca : ARKOROYAL
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.